| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,850 | 50,115 | 48,292 | 54,782 | | Cost of Revenue | (64,271) | 33,240 | 32,142 | 35,202 | | | Gross Profit | 113,121 | 16,875 | 16,150 | 19,580 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 101,899 | 3,271 | 3,343 | 3,726 | | Non Recurring | 11,419 | 16,389 | 1 | 52,935 | | Others | 3,679 | 3,763 | 3,981 | 4,066 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,546) | (6,548) | 8,825 | (41,147) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (811) | 3,002 | 133 | (154) | | Earnings Before Interest And Taxes | (4,687) | (3,546) | 8,958 | (41,301) | | Interest Expense | 4,291 | 4,279 | 4,359 | 5,366 | | Income Before Tax | (8,978) | (7,825) | 4,599 | (46,667) | | Income Tax Expense | (4,317) | (2,699) | 1,744 | (16,202) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,661) | (5,126) | 2,855 | (30,465) | | | Non-recurring Events | | Discontinued Operations | 25 | 109 | 34 | (126) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,636) | (5,017) | 2,889 | (30,591) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,636) | ($5,017) | $2,889 | ($30,591) |
|
0.02% Nasdaq 0.00%
Income Statement
